These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 14071519)

  • 21. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 22. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 23. HEPARIN FRACTIONATION IN THE STUDY OF LYTIC ACTIVITY.
    GREEN J
    J Clin Pathol; 1964 May; 17(3):316-8. PubMed ID: 14159470
    [No Abstract]   [Full Text] [Related]  

  • 24. [LEUKOCYTIC FIBRINOLYSIS].
    CAVIEZEL O; VOLLERY M; VANNOTTI A
    Schweiz Med Wochenschr; 1964 Jul; 94():1016-20. PubMed ID: 14243603
    [No Abstract]   [Full Text] [Related]  

  • 25. [USE OF SOME ENZYMES FOR THERAPEUTIC PURPOSES].
    KRUSHKOV I
    Suvr Med (Sofiia); 1963; 14():46-51. PubMed ID: 14064612
    [No Abstract]   [Full Text] [Related]  

  • 26. POSTOPERATIVE CHANGES IN THE COAGULATION FACTORS AND THE FIBRINOLYTIC SYSTEM.
    OLOW B
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:30-3. PubMed ID: 14199706
    [No Abstract]   [Full Text] [Related]  

  • 27. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
    Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract]   [Full Text] [Related]  

  • 28. [EPSILON-AMINOCAPROIC ACID AND FIBRINOLYSIS].
    VAIREL E; LANDE M; LEGER L
    Presse Med (1893); 1964 Mar; 72():945-6. PubMed ID: 14119753
    [No Abstract]   [Full Text] [Related]  

  • 29. THE EFFECT OF CHONDROMUCOPROTEIN ON THE SOLUBILITY AND PEROXIDATIC PROPERTIES OF HAEMOGLOBIN AND METHAEMALBUMIN IN AQUEOUS SOLUTION AND BLOOD.
    ANDERSON AJ
    Biochem J; 1965 Feb; 94(2):401-9. PubMed ID: 14348200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
    KOLLER F
    Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
    [No Abstract]   [Full Text] [Related]  

  • 31. [Research on the antifibrinolytic effect of 6-aminocaproic acid. III. Effect of 6-aminocaproic acid as an antidote to thrombolytic agents (plasmin, streptokinase)].
    GIBELLI A
    Gazz Int Med Chir; 1962 Nov; 66():2444-50. PubMed ID: 13947688
    [No Abstract]   [Full Text] [Related]  

  • 32. STREPTOKINASE AND PULMONARY EMBOLISM.
    BROWSE NL; JAMES DC
    Lancet; 1964 Nov; 2(7368):1039-43. PubMed ID: 14206016
    [No Abstract]   [Full Text] [Related]  

  • 33. PREPARATION, STABILIZATION AND SOME PROPERTIES OF PURIFIED HUMAN PLASMIN.
    KLINE DL; FISHMAN JB
    Thromb Diath Haemorrh; 1964 Apr; 11():75-84. PubMed ID: 14167117
    [No Abstract]   [Full Text] [Related]  

  • 34. THROMBOLYSIS STUDIED IN AN ARTIFICIAL CIRCULATION: THROMBI PREPARED IN VITRO IN A CHANDLER'S TUBE.
    MCNICOL GP; BAIN WH; WALKER F; RIFKIND BM; DOUGLAS AS
    Lancet; 1965 Apr; 1(7390):838-42. PubMed ID: 14263541
    [No Abstract]   [Full Text] [Related]  

  • 35. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 36. THE FORMATION, COMPOSITION AND FIBRINOLYTIC POTENTIAL OF CHONDROMUCOPROTEIN-FIBRINOGEN AND CHONDROMUCOPROTEIN-LIPOPROTEIN COMPLEXES IN HUMAN EUGLOBULIN FRACTIONS.
    ANDERSON AJ; LACK CH
    Clin Sci; 1964 Feb; 26():97-110. PubMed ID: 14117066
    [No Abstract]   [Full Text] [Related]  

  • 37. THE INACTIVATION OF STREPTOKINASE BY TAME.
    ROBERTS PS
    Can J Biochem; 1964 Dec; 42():1841-4. PubMed ID: 14241619
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by 6-aminocaproic acid.
    ABLONDI FB; HAGAN JJ; PHILIPS M; DE RENZO EC
    Arch Biochem Biophys; 1959 May; 82(1):153-60. PubMed ID: 13650650
    [No Abstract]   [Full Text] [Related]  

  • 39. EFFECT OF ANTICOAGULANT, FIBRINOLYTIC, AND ANTIFIBRINOLYTIC AGENTS ON EXPERIMENTAL HYALINE MEMBRANES.
    FUJIKURA T
    Am J Obstet Gynecol; 1964 Dec; 90():850-3. PubMed ID: 14241506
    [No Abstract]   [Full Text] [Related]  

  • 40. ROLE OF INHIBITORS OF FIBRINOLYSIS IN HEPATIC CIRRHOSIS.
    O'CONNELL RA; GROSSI CE; ROUSSELOT LM
    Lancet; 1964 Nov; 2(7367):990-1. PubMed ID: 14201669
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.